An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis

Timothy L. Vollmer, J. T. Phillips, A. D. Goodman, M. A. Agius, M. A. Libonati, J. L. Giacchino, J. S. Grundy

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences